MRI First, when it comes to Screening for Prostate Cancer

Submitted by rperez on Mon, 09/11/2023 - 18:26

A study shows that performing MRI scans before biopsy on men with high PSA scores could reduce prostate cancer death rates by almost 20%.

According to the American Cancer Society, 1 in 8 men will be diagnosed with prostate cancer during his lifetime. Currently, prostate cancer is the second leading cause of cancer death in American men, second only to lung cancer. And yet, despite these somewhat dire statistics, success rates for prostate cancer are actually higher than many other types of cancer.

Ablation Registry Trial

Submitted by steve on Tue, 12/28/2021 - 14:41

TULSA-PRO Ablation Registry (CARE Registry) trial

Patients who elect for the Tulsa-Pro procedure will also have the opportunity to participate in the Customized TULSA-PRO Ablation Registry (CARE Registry) trial.

A registry is a place where medical information related to your prostate cancer treatment is collected and stored for the purpose of conducting medical research.

Ishita Desai, MD

Submitted by steve on Fri, 10/22/2021 - 14:33

Upon graduating from medical school at New York Medical College after induction into the Alpha Omega Alpha honor society, Dr. Desai went on to complete a radiology residency at University of California, Los Angeles. Thereafter, she went on to complete a combined fellowship in Breast and Abdominal Imaging at the University of Southern California.

Neal Bost, MD

Submitted by steve on Tue, 10/19/2021 - 17:08

Dr. Neal Bost is a board-certified radiologist specializing in Body Imaging and Nuclear Radiology.

He attended Tulane University in New Orleans, LA for undergraduate (BS, Neuroscience), graduate (MS, Pharmacology), and medical school. He then completed Diagnostic Radiology residency at Kaiser Permanente Los Angeles Medical Center, followed by fellowship training in Nuclear Medicine & Molecular Imaging at LAC+USC Medical Center.

Subscribe to